Featured Research

from universities, journals, and other organizations

Lactate metabolism target halts growth in lung cancer model

Date:
April 10, 2014
Source:
Beth Israel Deaconess Medical Center
Summary:
Targeting the enzyme responsible for the final step of glucose metabolism not only halts tumor growth in non-small-cell lung cancer, but actually leads to regression of established tumors, new research shows. Importantly the new findings also show that cancer initiating cells -tumor cells that possess stem-cell like characteristics which can give rise to new tumors -- are susceptible to LDH-A inhibition.

Cancer cells generate energy differently than normal cells, a characteristic that helps them to survive and metastasize. A major goal in the field of cancer metabolism is to find ways to overcome this survival advantage.

Now a research team led by investigators in the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) has found that targeting the enzyme responsible for the final step of glucose metabolism not only halts tumor growth in non-small-cell lung cancer, but actually leads to the regression of established tumors.

Importantly the new findings, which appear online April 10 in the journal Cell Metabolism, also show that cancer initiating cells -tumor cells that possess stem-cell like characteristics which can give rise to new tumors -- are susceptible to LDH-A inhibition.

"We've known for almost 100 years that increased lactate production is associated with aggressive tumors," says the study's senior author Pankaj Seth, PhD, an investigator in the Division of Interdisciplinary Medicine and Biotechnology at BIDMC and Assistant Professor of Medicine at Harvard Medical School (HMS). "So our team had a straightforward question: If you were to inhibit the production of lactate, what would happen? And we found that not only did tumors stop growing, they actually regressed. Most exciting, we also showed that inhibition of LDH-A impacts cancer initiating cells, a population of aggressive tumor cells not targeted by most current therapies."

Altered energy metabolism is a defining biochemical characteristic of cancer cells, and was first observed nearly a century ago by German scientist Otto Warburg in what has now become known as the "Warburg Effect." While normal cells usually produce most of their energy needs from burning fuels using oxygen, cancer's energy production is dependent on sugar or glucose, a process known as fermentative glycolysis.

"Cancer cells rely on anaerobic fermentation for the conversion of glucose to lactate," explains Seth. "This state of fermentative glycolysis is catalyzed by the A form of the LDH enzyme. LDH-A is elevated in cancer cells, and this enables tumor cells to convert the majority of their glucose stores into lactate, regardless of oxygen availability. This shifts the function of glucose metabolites from simple energy production to accelerated cell growth and replication." For this reason, he explains, LDH-A and the possibility of inhibiting its activity has been identified as a promising target in cancer treatments focused on preventing cancer cells from proliferating.

Non-small cell lung cancer (NSCLC) is highly glycolytic, accounts for more than 85 percent of all lung cancers and is the leading cause of cancer deaths. Fermentative glycolysis is promoted in NSCLC through oncogenic mutations in two critical proteins, K-RAS and EGFR. The investigators, therefore, created inducible LDH-A mouse models of non-small cell lung cancer expressing oncogenic K-RAS and EGFR.

"We wanted an established tumor so that we could ascertain how much LDH-A inhibition was needed," says Seth. By genetically adjusting LDH-A levels and comparing the results with that of a small molecule inhibitor, the team showed that when LDH-A was inhibited, not only did the tumors stop growing, they actually regressed in size from the point they were before LDH-A inhibition.

Next, the investigators obtained a small molecule LDH-A inhibitor drug and observed similar effects in cell culture experiments. These results further demonstrated that blocking fermentative glycolysis impacted cancer initiating cells, the small population of tumor-forming, self-renewing cancer cells associated with aggressive disease and poor prognosis.

To investigate the metabolic consequences of LDH-A inhibition, Seth collaborated with co-corresponding author Teresa Fan, PhD, of the University of Kentucky. They conducted a metabolic analysis in which glucose atoms labeled with the stable isotope of carbon were followed as the glucose was converted through the glycolytic pathway into a variety of products. These experiments were carried out in cultured lung cancer cells in the mouse model and in thin slices of human lung tumor tissue.

"The latter is a modern version of Warburg's original experiment," explains Seth. "Together, these experiments showed that LDH-A inhibition affects metabolism, as expected, and underlies the regression of tumors when there is insufficient enzyme to support growth and survival."

"The field of cancer metabolism has seen a resurgence in recent years," adds study coauthor Vikas P. Sukhatme, MD, PhD, BIDMC Chief Academic Officer and Victor J. Aresty Professor of Medicine at HMS. "Findings such as these, conducted in genetically engineered mouse models that are the gold standard by which to judge this data, offer hope that drugs targeting metabolic pathways may one day become part of our armamentarium against this dreadful disease."


Story Source:

The above story is based on materials provided by Beth Israel Deaconess Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Han Xie, Jun-ichi Hanai, Jian-Guo Ren, Lev Kats, Kerri Burgess, Parul Bhargava, Sabina Signoretti, Julia Billiard, KevinJ. Duffy, Aaron Grant, Xiaoen Wang, PawelK. Lorkiewicz, Sabrina Schatzman, Michael Bousamra, AndrewN. Lane, RichardM. Higashi, TeresaW.M. Fan, PierPaolo Pandolfi, VikasP. Sukhatme, Pankaj Seth. Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells. Cell Metabolism, 2014; DOI: 10.1016/j.cmet.2014.03.003

Cite This Page:

Beth Israel Deaconess Medical Center. "Lactate metabolism target halts growth in lung cancer model." ScienceDaily. ScienceDaily, 10 April 2014. <www.sciencedaily.com/releases/2014/04/140410121937.htm>.
Beth Israel Deaconess Medical Center. (2014, April 10). Lactate metabolism target halts growth in lung cancer model. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2014/04/140410121937.htm
Beth Israel Deaconess Medical Center. "Lactate metabolism target halts growth in lung cancer model." ScienceDaily. www.sciencedaily.com/releases/2014/04/140410121937.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins